Journey Medical Corporation (DERM)

NCM – Real Time Price. Currency in USD

4.58

-0.20 (-4.29%)

At close: Mar 27, 2026, 4:00 PM EDT

4.77

+0.20 (4.36%)

After-hours: Mar 27, 2026, 7:15 PM EDT

About the company

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Key Executives

Name	Position
Dr. Lindsay Allan Rosenwald M.D.	Executive Chairman
Jaclyn Jaffe	Senior Director of Corporate Operations
Mr. Claude Maraoui	Founder, President, CEO & Director
Mr. Joseph M. Benesch	CFO & Corporate Controller
Mr. Louis Donati	Director of Market Access
Mr. Ramsey Alloush	COO, General Counsel & Company Secretary
Mr. Robert Nevin	Chief Commercial Officer